http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7186745-B2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-34 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-572 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-24 |
filingDate | 2002-03-04^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2007-03-06^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a5a8adf5b81be7fd1901d0b648796ff |
publicationDate | 2007-03-06^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-7186745-B2 |
titleOfInvention | Indolone derivatives having vascular damaging activity |
abstract | This invention relates to the use of compounds of Formula (I) as vascular damaging agents: wherein X is selected from: —O—, —S—, —S(O)—, —S(O 2 )—, —N(R 5 )—, —C(O)—, —C(O)N(R 5 )—, —N(R 5 )C(O)—, —S(O2)N(R 5 )—, or —N(R 5 )S(O 2 )—; R 1 is independently selected from: amino, halo, hydroxy, —OPO 3 H 2 , C 1-4 alkyl, or C 1-4 alkoxy, wherein the amino group is optionally substituted by an amino acid residue and the hydroxy group is optionally esterified; R 2 is selected from: hydrogen or C 1-4 alkyl; R 3 is selected from: hydrogen, halo, hydroxy, hydroxyC 1-4 alkyl, cyano, cyanoC 1-4 alkyl, carboxy, carboxyC 1-4 alkyl, C 1-4 alkanoyl, C 1-4 alkanoylC 1-4 alkyl, carbamoyl, carbamoylC 1-4 alkyl, C 1-4 alkoxy, C 1-4 alkoxycarbonyl, C 1-4 alkoxycarbonylC 1-4 alkyl, C 1-4 alkoxycarbonylamino, amino, N—C 1-4 alkylamino, NN-diC 1-4 alkylamino, aminoC 1-4 alkyl, N—C 1-4 alkylaminoC 1-4 alkyl, NN-diC 1-4 alkylaminoC 1-4 alkyl, ureido, or C 1-4 alkylureyleno; R 4 is independently selected from: C 1-4 alkyl, C 1-4 alkoxy or halo; R 5 is selected from: hydrogen or C 1-4 alkyl; n is 0 or 1; p is 0, 1, 2 or 3; and q is 0, 1 or 2; or a salt, pro-drug or solvate thereof. The invention also relates to novel compounds of Formula (I) and to processes for the preparation of compounds of Formula (I). |
priorityDate | 2001-03-06^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 824 of 824.